1. Home
  2. VIR vs KRNT Comparison

VIR vs KRNT Comparison

Compare VIR & KRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • KRNT
  • Stock Information
  • Founded
  • VIR 2016
  • KRNT 2002
  • Country
  • VIR United States
  • KRNT Israel
  • Employees
  • VIR N/A
  • KRNT N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • KRNT Industrial Machinery/Components
  • Sector
  • VIR Health Care
  • KRNT Industrials
  • Exchange
  • VIR Nasdaq
  • KRNT Nasdaq
  • Market Cap
  • VIR 706.4M
  • KRNT 845.4M
  • IPO Year
  • VIR 2019
  • KRNT 2015
  • Fundamental
  • Price
  • VIR $4.38
  • KRNT $15.32
  • Analyst Decision
  • VIR Strong Buy
  • KRNT Strong Buy
  • Analyst Count
  • VIR 8
  • KRNT 5
  • Target Price
  • VIR $30.25
  • KRNT $31.40
  • AVG Volume (30 Days)
  • VIR 1.0M
  • KRNT 380.7K
  • Earning Date
  • VIR 08-06-2025
  • KRNT 08-06-2025
  • Dividend Yield
  • VIR N/A
  • KRNT N/A
  • EPS Growth
  • VIR N/A
  • KRNT N/A
  • EPS
  • VIR N/A
  • KRNT N/A
  • Revenue
  • VIR $19,000,000.00
  • KRNT $207,639,000.00
  • Revenue This Year
  • VIR N/A
  • KRNT $10.86
  • Revenue Next Year
  • VIR $0.56
  • KRNT $12.68
  • P/E Ratio
  • VIR N/A
  • KRNT N/A
  • Revenue Growth
  • VIR N/A
  • KRNT N/A
  • 52 Week Low
  • VIR $4.16
  • KRNT $12.78
  • 52 Week High
  • VIR $14.45
  • KRNT $34.29
  • Technical
  • Relative Strength Index (RSI)
  • VIR 35.16
  • KRNT 34.46
  • Support Level
  • VIR $4.33
  • KRNT $14.76
  • Resistance Level
  • VIR $4.57
  • KRNT $15.57
  • Average True Range (ATR)
  • VIR 0.22
  • KRNT 0.85
  • MACD
  • VIR -0.02
  • KRNT -0.05
  • Stochastic Oscillator
  • VIR 21.53
  • KRNT 39.20

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

Share on Social Networks: